NEUROTOXICITY ASSOCIATED WITH DEFEROXAMINE THERAPY

被引：24
作者：
FREEDMAN, MH
BOYDEN, M
TAYLOR, M
SKARF, B
机构：
[1] UNIV TORONTO,HOSP SICK CHILDREN,DIV AUDIOL,TORONTO M5G 1X8,ONTARIO,CANADA
[2] UNIV TORONTO,HOSP SICK CHILDREN,DIV NEUROL,TORONTO M5G 1X8,ONTARIO,CANADA
[3] UNIV TORONTO,HOSP SICK CHILDREN,DEPT PEDIAT,TORONTO M5G 1X8,ONTARIO,CANADA
[4] UNIV TORONTO,HOSP SICK CHILDREN,DEPT OTOLARYNGOL,TORONTO M5G 1X8,ONTARIO,CANADA
来源：
TOXICOLOGY | 1988年 / 49卷 / 2-3期
关键词：
D O I：
10.1016/0300-483X(88)90010-8
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：283 / 290
页数：8
相关论文
共 16 条
[1]  
BLAKE DR, 1985, Q J MED, V56, P345
[2]  
BORGNAPIGNATTI C, 1984, LANCET, V1, P681
[3]   DEPLETION OF EXCESSIVE LIVER IRON STORES WITH DESFERRIOXAMINE [J].
COHEN, A ;
MARTIN, M ;
SCHWARTZ, E .
BRITISH JOURNAL OF HAEMATOLOGY, 1984, 58 (02) :369-373
[4]   RESPONSE TO LONG-TERM DEFEROXAMINE THERAPY IN THALASSEMIA [J].
COHEN, A ;
MARTIN, M ;
SCHWARTZ, E .
JOURNAL OF PEDIATRICS, 1981, 99 (05) :689-694
[5]  
DAVIES SC, 1983, LANCET, V2, P181
[6]   AUDITORY INVOLVEMENT IN THALASSEMIA MAJOR [J].
DEVIRGILIIS, S ;
ARGIOLU, F ;
SANNA, G ;
CORNACCHIA, G ;
COSSU, P ;
CAO, A ;
MALLARDI, V ;
PUXEDDU, P .
ACTA HAEMATOLOGICA, 1979, 61 (04) :209-215
[7]  
ESTROV Z, 1987, BLOOD, V69, P757
[8]  
GUERIN A, 1985, LANCET, P39
[9]  
LAKHANPAL V, 1984, OPHTHALMOLOGY, V91, P443
[10]  
LEDERMAN HM, 1984, BLOOD, V64, P748
12